Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
PLoS One. 2011 Jan 27;6(1):e16567. doi: 10.1371/journal.pone.0016567.
Cognitive impairment resulting from cerebrovascular insufficiency has been termed vascular cognitive impairment, and is generally accepted to be distinct from Alzheimer's disease resulting from a neurodegenerative process. However, it is clear that this simple dichotomy may need revision in light of the apparent occurrence of several shared features between Alzheimer's disease and vascular cognitive impairment. Nevertheless, it still remains largely unknown whether the burden of vascular- and Alzheimer-type neuropathology are independent or interdependent. Therefore, we investigated whether chronic cerebral hypoperfusion influences cognitive ability or amyloid β deposition in amyloid precursor protein (APP) overexpressing transgenic mice.
Two months old mice overexpressing a mutant form of the human APP bearing both the Swedish and Indiana mutations (APP(Sw/Ind)-Tg mice), or their wild-type littermates, were subjected to chronic cerebral hypoperfusion with bilateral common carotid artery stenosis (BCAS) using microcoils or sham operation. Barnes maze test performance and histopathological findings were analyzed at eight months old by 2 × 2 factorial experimental designs with four groups.
BCAS-operated APP(Sw/Ind)-Tg mice showed significantly impaired learning ability compared to the other three groups of mice. Two-way repeated measures analysis of variance showed a synergistic interaction between the APP genotype and BCAS operation in inducing learning impairment. The cognitive performances were significantly correlated with the neuronal densities. BCAS significantly reduced the density of Nissl-stained neurons and silver-stained cored plaques in the hippocampus of APP(Sw/Ind)-Tg mice but increased the amount of filter-trap amyloid β in the extracellular-enriched soluble brain fraction, compared to those from sham operated mice.
The results suggest interaction between chronic cerebral hypoperfusion and APP(Sw/Ind) overexpression in cognitive decline in mice through enhanced neuronal loss and altered amyloid β metabolism.
由脑血管功能不全引起的认知障碍被称为血管性认知障碍,通常与由神经退行性过程引起的阿尔茨海默病不同。然而,鉴于阿尔茨海默病和血管性认知障碍之间显然存在一些共同特征,这种简单的二分法可能需要修正。尽管如此,血管性和阿尔茨海默型神经病理学的负担是否是独立的还是相互依存的,在很大程度上仍然未知。因此,我们研究了慢性大脑低灌注是否会影响载脂蛋白 APP 过表达转基因小鼠的认知能力或淀粉样 β 沉积。
用微线圈或假手术对 2 个月大的过表达携带瑞典和印第安纳突变的人类 APP 突变体(APP(Sw/Ind)-Tg 小鼠)或其野生型同窝小鼠进行慢性大脑低灌注,以进行双侧颈总动脉狭窄(BCAS)。通过 2×2 析因实验设计,用 4 组分析 8 个月大时的 Barnes 迷宫测试表现和组织病理学发现。
BCAS 手术 APP(Sw/Ind)-Tg 小鼠的学习能力明显低于其他三组小鼠。双向重复测量方差分析显示,APP 基因型和 BCAS 手术在诱导学习障碍方面存在协同作用。认知表现与神经元密度显著相关。BCAS 显著降低了 APP(Sw/Ind)-Tg 小鼠海马区尼氏染色神经元密度和银染核心斑块密度,但增加了细胞外富含可溶性脑部分的滤器陷阱淀粉样 β 量,与假手术组相比。
结果表明,慢性大脑低灌注和 APP(Sw/Ind)过表达通过增强神经元丢失和改变淀粉样 β 代谢相互作用,导致小鼠认知能力下降。